- Exchange: New York
- Sector: Consumer, Non-cyclical
- Industry: Pharmaceuticals
- Sub-Industry: Medical-Drugs
Snapshot for Sanofi (SNY)
| Open: | 54.0500 | Day's Range: | 54.0300 - 54.6800 | Volume: | 1,646,118 |
|---|---|---|---|---|---|
| Previous Close: | 54.2100 | 52wk Range: | 33.0300 - 55.7700 | 1-Yr Rtn: | +65.00% |
Key Statistics for SNY
| Current P/E Ratio (ttm) | - |
|---|---|
| Estimated P/E(12/2013) | 14.5747 |
| Relative P/E vs. SPX | - |
| Earnings Per Share (EUR) (ttm) | - |
| Est. EPS (EUR) (12/2013) | 2.9150 |
| Est. PEG Ratio | 2.4311 |
| Market Cap (M USD) | 145,236.53 |
| Shares Outstanding (M) | 2,664.89 |
| 30 Day Average Volume | 2,444,215 |
| Price/Book (mrq) | - |
| Price/Sale (ttm) | - |
| Dividend Indicated Gross Yield | 3.41% |
| Cash Dividend (USD) | 1.5780 |
| Last Dividend | 05/06/2013 |
| 5 Year Dividend Growth | 2.67% |
| Next Earnings Announcement | 07/26/2013 |
mrq = Most Recent Quarter; ttm = Trailing Twelve Months
Income Statement for SNY
Company Profile & Key Executives for SNY
Sanofi is a global pharmaceutical company that researches, develops and manufactures prescription pharmaceuticals and vaccines. The Company develops cardiovascular, thrombosis, metabolic disorder, central nervous system, internal medicine and oncology drugs, and vaccines.
| Serge Daniel WeinbergChairman | Christopher A Viehbacher "Chris"Chief Executive Officer |
| Hanspeter SpekPres:Global Operations | Elias A ZerhouniPres:Global Research & Dev |
Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
-
SNY News
-
Industry News
Advertisement
- 1
- 2
- 3
- 4
- 5
Advertisement
Sponsored Links
Advertisements
Rate this Page